SEC Form 4 · accession 0001209191-18-003058
Ignyta, Inc. · RXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Bristol
Director
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 5, 2017 | J | 178 | $0.00 | A | 21,845 | I | Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution from FHM Life Sciences VIII, L.P. of which the reporting person is a limited partner.
- F2The reporting person's original Form 3 and subsequently filed Forms 4 incorrectly reported direct beneficial ownership rather than indirect beneficial ownership through The Bristol Living Trust.